Choi YJ, Kim DS, Hoon Sung Y, Kim DH, et al. The reversible fourth-generation EGFR tyrosine kinase inhibitor OBX02-011 overcomes C797S-mediated resistance in lung cancer. Cancer Res 2022 Jun 14. pii: 704898. doi: 10.1158/0008-5472.CAN-22-0394.
PMID: 35700239